Cite
HARVARD Citation
Micallef, I. et al. (n.d.). Safety and efficacy of upfront plerixafor + G‐CSF versus placebo + G‐CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non‐Hodgkin's lymphoma or multiple myeloma. American journal of hematology. 88 (12), pp. 1017-1023. [Online].